Senior Director, Clinical Pharmacology job

Organization
Allergan
Job Location
Jersey City, NJ
Job Description

In early 2015, Actavis completed the acquisition of Allergan. This combination united two growing, successful and profitable companies into a unique, global pharmaceutical company and a leader in a new industry model - Growth Pharma. In June 2015, the combined company changed its corporate name to Allergan plc and its stock ticker to NYSE:AGN.
Today, our nearly 30,000 talented global employees are creating an unrivaled foundation for long-term growth. We combine highly regarded brands and a best-in-class generics business with an enviable pipeline and lean, reliable operations to drive value for customers.
Join one of the world's fastest growing specialty pharmaceutical companies!
At Allergan you will have the opportunity to thrive in a fast-paced, strategic environment where bold, innovative thinking isn't just welcomed, it's encouraged. Across all functions, we relish the opportunity to help our people fulfill their potential. Our rapid growth strategy means plenty of stretch assignments and opportunities to step into the spotlight.
Position Description
Reporting to the Executive Director, Clinical Pharmacology, the successful candidate will be an integral team member of the Allergan Non-Clinical and Translational Sciences organization, a team of approximately 80 full-time employees across several functional areas between East and West Coast. The successful candidate will be working closely with non-clinical, clinical and modeling & simulation (M&S) functions to support programs across multiple therapeutic areas and at various stages (preclinical through Phase 4).

Requirements:
Main Areas of Responsibilities
• Provide scientific leadership and expertise ...cont.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.